Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
While that study did not report runaway tumor growth either, the lack of a spectacular reduction in tumor size, suggests BPC-157 offers no anti-cancer benefit and it leaves open the worry that it could even accelerate malignancy under the right conditions
Generally well-tolerated
Angiogenesis promotion through TB-500 establishes new blood vessel networks in healing tissues
Standard daily dose: 2 mg (2000 mcg) once daily subcutaneously (FDA-approved protocol)
Even experienced users should start at the beginning of the escalation protocol and let their body adapt to this specific triple-agonist mechanism
We reserve the right to revise these Terms at any time
US$ 24.35
US$ 20.90
US$ 22.33
US$ 28.75
US$ 26.77
